Castle Biosciences CSTL Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$12.83M+46.9% | -$24.16M-97.4% | -$12.24M-29.3% | -$9.47M-86.7% | -$5.07M-128% | ||
| $14.94M-63.4% | $40.77M-4.7% | $42.76M+0.6% | $42.49M+0.2% | $42.42M+165% | ||
| $44.49M-3.1% | $45.89M-0.1% | $45.93M-2.0% | $46.85M-4.0% | $48.82M-3.0% | ||
| $48.25M-25.0% | $64.35M+4.2% | $61.78M-1.1% | $62.49M-4.8% | $65.67M+1.2% | ||
| $43.74M+21.4% | $36.02M-1.1% | $36.4M+30.3% | $27.95M+16.9% | $23.91M-15.6% | ||
| —— | —— | —— | —— | —— | ||
| -$10.54M-49.3% | -$7.06M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $4.52M-84.0% | $28.33M+11.6% | $25.38M-26.5% | $34.54M-17.3% | $41.75M+14.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Castle Biosciences generate?
- Castle Biosciences (CSTL) generated $48.3M in operating cash flow over the trailing twelve months.
- What is Castle Biosciences's free cash flow?
- After $43.7M of capital expenditures, Castle Biosciences's free cash flow was $4.5M over the trailing twelve months, down 89.2% year over year.
- Where does Castle Biosciences's cash flow data come from?
- Every line is extracted from Castle Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
